Trial intelligence / Profile preview

Induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced cervical cancer

ChiCTR-TRC-11001832Phase 2Completed

Sponsor
Xijing Hospital
Start
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of cisplatin + radiotherapy in Cervical Cancer (CC) (2 arms), sponsored by Xijing Hospital. Primary endpoints: efficacy, disease-free survival and 4 more. Started Oct 2010; status: completed.

02

Drugs

cisplatin + radiotherapy
03

Conditions

Cervical Cancer (CC)

Beyond the preview

Go deeper on ChiCTR-TRC-11001832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call